Greater Manchester, East Cheshire and Glossop Abdominal Aortic Aneurysm (AAA) Service

Description

INTENTION TO AWARD The aim of the NHS AAA Screening Programme is to reduce AAA-related mortality in service users who are eligible by detecting aneurysms at an early stage, ensuring appropriate surveillance and referral if required, and improving outcomes. This is through the provision of a systematic population-based screening programme for men and individuals assigned male gender at birth during the year, 1st April to 31st March, in which they turn 65 and, on request, for men over 65 years. The Relevant Authority intends to award contracts for the above Lots to existing providers under Direct Award C under the Health Care Services (Provider Selection Regime) Regulations 2023. The Relevant Authority are undertaking a DAP C to award Greater Manchester, East Cheshire and Glossop Abdominal Aortic Aneurysm (AAA) Services to the existing provider. The services will commence on 01 April 2025 with the contract concluding on 31 March 2028. The lifetime value of the contract is £2,376,360. This contract is divided into lots: No Lot 1: The proposed contracting arrangements are not changing considerably. The relevant authority is of the view that the existing provider is satisfying the existing contract and will likely satisfy the proposed contract to a sufficient standard. Provider has met all the requirements within Regulation 20 - compliance check. No outstanding performance issues and provider has passed all applicable elements of the key criteria when assessed against service requirements. The procurement is not to conclude a framework agreement or to award a contract based on a framework agreement.